Abstract
Skin injury can result in inflammatory responses and increased sensitivity to touch. Corticotropin releasing factor (CRF), when administered locally or systemically, can reduce the inflammatory and hyperalgesic processes after skin injury. However, the mechanisms that control its effects are unclear. Doxorubicin injection produced inflammation, increased sensitivity to touch and more sensitive blink responses in eyelids of adult rabbits, and local injection of CRF reduced these changes. Doxorubicin alone resulted in a significant ingrowth of nerve fibers as determined by morphometric analysis of PGP 9.5 and substance P immunohistochemistry. Treatment with CRF significantly reduced this nerve fiber ingrowth, and a CRF antagonist partially blocked this protective effect. Thus, CRF has a potent tissue protective effect when administered locally after a vesicant-induced injury, and one mechanism of action is the reduction of nerve fiber ingrowth and sensitivity of the eyelid to touch.
References
Jan 1, 1978·Plastic and Reconstructive Surgery·D G Bowers, J B Lynch
Sep 1, 1976·Cancer·R RudolphR A Pattillo
May 1, 1991·Peptides·G C GaoE T Wei
Jan 1, 1989·Histochemistry·C J DalsgaardA Haegerstrand
Nov 20, 1989·Brain Research·L R PoreeE T Wei
Oct 23, 1995·FEBS Letters·A SlominskiM Mihm
Jan 1, 1994·The Journal of Pathology·X H GuJ M Polak
Jan 14, 1997·European Journal of Pharmacology·S G CorreaI D Bianco
Feb 28, 1998·Ophthalmology·J D Wirtschafter, L K McLoon
Dec 22, 1999·Pain·W R Lariviere, R Melzack
Jun 1, 2001·Regulatory Peptides·A BozkurtB C Yeğen
Feb 16, 2002·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·L K McLoonJ D Wirtschafter
Aug 2, 2003·Nature Medicine·Christoph SteinHalina Machelska
Nov 25, 2004·Pain·Alexander BrackChristoph Stein
Jan 22, 2005·Pain·Derek C MolliverBrian M Davis
Apr 20, 2005·Pain·Paul W WacnikMarna E Ericson